Nanite Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nanite Inc. - overview
Established
2021
Location
Boston, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2021 by its CEO Sean Kevlahan, and co-founders Thomas Neenan, and Shashi Murthy, Nanite Inc. operates as an AI-driven non-viral gene delivery company that helps in developing a new class of programmable polymer nanoparticles. In February 2023, Nanite Inc. raised USD 6 million in seed funding led by Zetta Venture Partners, with participation from Arkitekt Ventures.
Nanite Inc. provides the SAYER platform, which combines cutting-edge high-throughput experimental and computational methods to design cargo and tissue specific delivery vehicles. Its artificial intelligence models guide functional chemistry to design therapeutically relevant gene delivery vehicles and provide biological screening, as well as multiple polymers tested for trafficking, tropism, and expression in a single pass. The company plans to use the seed funding to accelerate the development of its AI-driven platform.
Current Investors
Zetta Venture Partners, Arkitekt Ventures, Cystic Fibrosis Foundation
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.nanitebio.com
Verticals
Artificial Intelligence, Cloud Computing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.